In the latest iteration of See Your Risks, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart ...

Oelrich said there was also no reason to split Bayer, whose businesses span agrochemicals, pharmaceuticals and non-prescription drugs. "We function with three very independent businesses," he said.

On January 21, a Northern District of California Court denied Plaintiff Tevra Brands LLC’s (“Tevra’s”) Motion for a New Trial, after a Jury found ...

Republicans in the Iowa Senate advanced a bill Wednesday that would limit lawsuits by Iowans seeking compensation for ...

Bayer expects its pharmaceutical business to return to growth in 2027, unit President Stefan Oelrich said Monday. The German conglomerate is planning to launch new therapies — one that treats a ...

Berlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), ...

Bayer has filed its mineralocorticoid receptor antagonist (MRA) finerenone as a treatment for a common form of heart failure ...

This collaboration supports the "Protect Your Heart" national awareness campaign, sponsored by Bayer and Al-Dawaa Medical ...

Bayer seeks European marketing approval for use of finerenone in adult patients with HF with a left ventricular ejection fraction (LVEF) of =40%: Berlin Tuesday, February 4, 2025, ...

FILE PHOTO: Stefan Oelrich, member of the Board of Management and head of Pharmaceuticals Division of Bayer AG, speaks during an interview on the sidelines of the 38th Annual JP Morgan Healthcare ...